Epidemiological studies consistently demonstrate that patients with multiple sclerosis are
almost universally infected with Epstein–Barr virus (EBV) and that the risk of developing the …

Symptomatic primary Epstein-Barr virus (EBV) infection and elevated humoral immune
responses to EBV are associated with an increased risk of developing multiple sclerosis …

Mounting evidence indicates that infection with Epstein–Barr virus (EBV) has a major role in
the pathogenesis of multiple sclerosis (MS). Defective elimination of EBV‐infected B cells by …

Epstein-Barr virus (EBV) has been associated with multiple sclerosis (MS), however, most
studies examining the relationship between the virus and the disease have been based on …

Epstein-Barr virus (EBV) is one of the most common and successful human viruses, infecting
more than 90% of the world's adult population. Despite its strong tumorigenic potential, most …

Epstein–Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-
reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T …

Recent seroepidemiologic and pathologic evidence suggests that prior infection with
Epstein-Barr virus (EBV) may be necessary for the development of multiple sclerosis (MS) …

An increased frequency of antiviral CD8+ T cells is seen in chronic viral infections. During
herpes virus infections the expanded CD8+ T cells are thought to control the reactivation of …

Multiple sclerosis (MS) is a common chronic inflammatory demyelinating disease of the
central nervous system (CNS) causing progressive disability. Many observations implicate …

Multiple sclerosis (MS) is an autoimmune demyelinating disease with progressive
neurodegeneration and complex etiology likely involving genetic and environmental factors …